Related Experiment Video
Updated: Aug 30, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Hepatitis C seropositivity among chronic liver disease patients in Hazara, Pakistan
Taher Salim Khan1, Farhat Rizvi, Abdur Rashid
1Department of Pharmacology, Ayub Medical College, Abbottabad, Pakistan. tahersalim@ayubmed.edu.pk
Insights
Hepatitis C virus (HCV) infection is common in Pakistan, with over 40% of patients tested for chronic liver disease found to be seropositive. This high prevalence highlights the need for increased awareness and testing for HCV in the region.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Hepatitis C virus (HCV) infection presents a growing public health challenge in developing nations, notably Pakistan.
- The study aimed to determine the prevalence of HCV seropositivity among individuals seeking hepatitis testing at a referral laboratory.
Purpose of the Study:
- To document the frequency of Hepatitis C seropositive individuals.
- To assess the prevalence of anti-HCV antibodies in the Hazara division.
Main Methods:
- Serum samples were collected from 614 patients (436 males, 178 females) with chronic liver disease between July 2000 and July 2002.
- Hepatitis C virus (HCV) testing was performed using the DOT immunoassay for anti-HCV antibodies.
Main Results:
- A total of 251 (40.8%) individuals tested positive for anti-HCV antibodies.
- Prevalence was 42.2% in males and 37.6% in females, a difference not statistically significant.
- The male to female ratio referred for testing was 2.4:1.
Conclusions:
- A high frequency of HCV seropositivity exists in both sexes among patients with chronic liver disease in the Hazara division.
- The observed HCV prevalence aligns with figures reported elsewhere in Pakistan and other developing countries.
- The higher referral rate of males for testing may reflect societal factors influencing healthcare-seeking behavior.
Background:
Hepatitis C is rapidly emerging as a major health problem in developing countries including Pakistan. The present study was conducted to document the frequency of Hepatitis C seropositive individuals reporting for hepatitis testing at a referral laboratory.
Methods:
Serum samples were collected from 614 people (436 males and 178 females) referred for chronic liver disease from all parts of Hazara division during the period July 2000 to July 2002. Hepatitis tests were performed by DOT immuno-chromatographic method for anti HCV antibodies.
Results:
A total of 251 (40.8%) sera tested positive for anti HCV antibodies, including 184 males (73.3%) and 67 females (26.7%). Of 436 males, 184 (42.2%) tested positive, while among females, 67/178 (37.6%) tested positive; this difference is not statistically significant. However the male/female ratio referred for testing was 2.4:1.
Conclusion:
There is a high frequency of HCV seropositive individuals of both sexes among patients referred for chronic liver disease. The frequencies obtained for Hazara division compare well with figures from other parts of Pakistan as well as developing countries. The male/female ratio could simply be a reflection of more males coming for treatment and testing in our setting.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Cytomegalovirus Disease
Cirrhosis II: Pathophysiology